Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study
NCT ID: NCT05218174
Last Updated: 2025-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2022-04-22
2023-12-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home-based Exercise Program in Patients With the Post-COVID-19 Condition
NCT05360563
Effects of Exercise Training on Patients With Long COVID-19
NCT05961462
The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19
NCT04647734
The COVID-19 Pandemic and Exercise Study
NCT04400279
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)
NCT04595773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Examine participant compliance (in-person attendance, online engagement) with the 8-week exercise training program including in-person exercise sessions, cognitive performance training, and virtual exercise sessions delivered via a mobile application.
To determine if compliance with the 8-week exercise training program is associated with improvement in functional, cognitive, and emotional health outcomes.
Determine if there is a maintenance effect for individuals randomized into the 8-week exercise training program by comparing their outcomes at the end of the 8-week training exercise program to their outcomes at the end of their trial participation (16 weeks).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise training program
Participants in this arm will complete an 8-week exercise training program comprised of an initial functional assessment to create an exercise prescription, followed by 7 in-person weekly sessions. Each session consisting of approximately 50 minutes of individualized exercise training and approximately 10 minutes of cognitive training via the Sports Academy "CogPT" iPad app. All participants will receive exercise and cognitive training delivered weekly in a group-based setting at Sports Academy within the Star in Frisco, Texas during the intervention period. Additionally, they will have access to daily workouts pushed to their phone via the MOVE exercise app developed by our team.
Exercise Prescription
In this prospective, randomized control trial, the investigators will compare functional exercise capacity, cognitive performance, and emotional well-being at baseline and following 2 conditions: (1) an 8-week exercise training program (intervention) or (2) no training program (control). Participants will be randomized using a 1:1 randomization scheme into either the intervention or control group. After 8 weeks, participants in the wait-list control group will begin the intervention for the next 8 weeks and activity undergone by participants first randomized into the intervention group will remain under observation.
No training program
Participants in this arm will be wearing the WHOOP band for 8-weeks but will not be exposed to any active intervention.
Exercise Prescription
In this prospective, randomized control trial, the investigators will compare functional exercise capacity, cognitive performance, and emotional well-being at baseline and following 2 conditions: (1) an 8-week exercise training program (intervention) or (2) no training program (control). Participants will be randomized using a 1:1 randomization scheme into either the intervention or control group. After 8 weeks, participants in the wait-list control group will begin the intervention for the next 8 weeks and activity undergone by participants first randomized into the intervention group will remain under observation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Prescription
In this prospective, randomized control trial, the investigators will compare functional exercise capacity, cognitive performance, and emotional well-being at baseline and following 2 conditions: (1) an 8-week exercise training program (intervention) or (2) no training program (control). Participants will be randomized using a 1:1 randomization scheme into either the intervention or control group. After 8 weeks, participants in the wait-list control group will begin the intervention for the next 8 weeks and activity undergone by participants first randomized into the intervention group will remain under observation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reported history of COVID-19 diagnosis
* Self-reported ongoing symptoms of PASC \>4 weeks after initial infection
Exclusion Criteria
* COVID-19 infection occurring \> 6 months prior to screening date
* Contraindications to Symptom-limited Maximal Exercise Testing
* Individuals without access to a device with iOS (apple devices such as iPhone, iPad, MacBook, etc.)
* Patient-reported diagnosis of severe arterial hypertension
* Patient reported metabolic disease
* Patient reported uncontrolled asthma
* Inmates
* Pregnancy
* Patient reported supplemental O2 use
* Presence of beards
* Patient reported diagnosis of claustrophobia
* Non-English speaking
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sports Academy
UNKNOWN
Baylor Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simon Driver
Research Center Director - The STAR at Frisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baylor Scott and White Sports Therapy and Research
Frisco, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
021-347
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.